trimethaphan-camsylate has been researched along with Hypotension* in 52 studies
52 other study(ies) available for trimethaphan-camsylate and Hypotension
Article | Year |
---|---|
Effects of a depressor on cochlear blood flow and perilymphatic oxygen tension.
To clarify the characteristics of the blood circulation in the cochlea, we investigated the relationship between cochlear blood flow and perilymphatic oxygen tension in guinea pigs with trimetaphan camsilate induced hypotension. Cochlear blood flow was measured by laser Doppler flowmetry, and perilymphatic oxygen tension by a polarographic method. Cochlear blood flow generally paralleled systemic blood pressure, while perilymphatic oxygen tension showed a slower response to the decrease of systemic blood pressure. Although there were individual differences in the changes of systemic blood pressure, cochlear blood flow and perilymphatic oxygen tension, they were found to be dose dependent. Since hypotension induced by trimetaphan camsilate is fairly reproducible in the dose range of this experiment, this drug can be used as a ganglion blocking agent in experiments on cochlear blood flow and perilymphatic oxygen tension during systemic hypotension. The change of perilymphatic oxygen tension with a slower response could be considered to be a factor in the homeostasis in the inner ear fluid. Topics: Animals; Blood Pressure; Cochlea; Dose-Response Relationship, Drug; Guinea Pigs; Hypotension; Lasers; Oxygen; Perilymph; Regional Blood Flow; Trimethaphan; Vasodilator Agents | 1991 |
Effect of carotid artery occlusion and ganglionic blockade on regional blood flows and intestinal damage after haemorrhagic hypotension in the rat.
The effects of cerebral ischaemia by carotid artery occlusion and of a ganglionic blocking agent (Arfonad) on cardiac output and regional blood flows were studied after 15 min of haemorrhagic hypotension (mean arterial pressure 50 mmHg) in the rat. The microsphere technique was used for blood flow determinations. Animals subjected to haemorrhagic hypotension and simultaneous carotid artery occlusion (group BC) exhibited a stronger immediate vasoconstrictor response than animals subjected to haemorrhagic hypotension only (group B) and more blood had to be withdrawn to achieve stable hypotension at 50 mmHg (2.6 +/- 0.1 vs. 2.2 +/- 0.4 ml per 100 g body weight (body wt); P less than 0.05). However, group B showed the same decrease in cardiac output as group BC, but the blood flows of the kidneys, spleen, intestine, liver and skin were less deranged at the end of the hypotensive period. Groups B and BC exhibited similar intestinal ischaemic mucosal damage, measured as leakage of [125I]albumin. When induction of haemorrhagic hypotension was combined with ganglionic blockade administration (Arfonad) and carotid artery occlusion (group ABC), significantly less blood had to be withdrawn than in groups BC (1.6 +/- 0.2 vs. 2.6 +/- 0.1 ml per 100 g body wt; P less than 0.05). The blood flows of the kidneys, small intestine, liver, spleen and skin were less compromised in group ABC. In addition, group BC had more profound metabolic acidosis and were more haemoconcentrated than group ABC; moreover, group BC, tended to be hypoglycaemic and showed intestinal mucosal damage, whereas neither of these effects occurred in group ABC.(ABSTRACT TRUNCATED AT 250 WORDS) Topics: Animals; Brain Ischemia; Cardiac Output; Ganglionic Blockers; Hemorrhage; Hypotension; Intestinal Mucosa; Intestine, Small; Male; Rats; Rats, Inbred Strains; Regional Blood Flow; Trimethaphan | 1986 |
Calculation of brain elastic parameters in vivo.
In an earlier study [Am. J. Physiol. 232 (Regulatory Integrative Comp. Physiol. 1): R27-R30, 1977], we defined the concept of brain elastic response in vivo as measured by a pressure-depth ratio (G0) derived from a graphic analysis of the elastic response tests. These tests have shown that brain elastic response in vivo is sensitive to changes in the intracranial system and that the response is nonlinear. In this study we identify a second parameter, G0, a second-order pressure-depth ratio that characterizes the nonlinear behavior and, along with G0, can be evaluated from a mathematical relation that models the experimental results obtained from the elastic response test. The equation is a logarithmic function relating the pressure and the subpial insertion depth. From this we obtain G0 and G0 as the slope and curvature of the response function at the subpial position. In animal experiments we correlated the changes in these parameters with those of cerebral hemodynamics during hemorrhagic and drug-induced hypotension. The calculated values of G0 and G0 are reproducible and reflect changes in cerebral blood flow and/or volume. Topics: Animals; Blood Pressure; Brain; Cerebrovascular Circulation; Dogs; Elasticity; Femoral Artery; Hemorrhage; Hypotension; Intracranial Pressure; Models, Neurological; Nitroprusside; Regional Blood Flow; Trimethaphan; Vascular Resistance; Vasodilator Agents | 1984 |
Pharmacologically induced profound arterial hypotension in the anesthetized dog.
Topics: Adenosine; Anesthesia, General; Animals; Arteries; Blood Pressure; Dipyridamole; Dogs; Electrolytes; Gases; Heart Rate; Hypotension; Nitroprusside; Trimethaphan | 1983 |
TRIMETHAPHAN CAMSYLATE IN HEMORRHAGIC SHOCK.
Topics: Blood; Blood Pressure; Dogs; Heart; Hypotension; Lactates; Metabolism; Pharmacology; Physiology; Research; Shock; Shock, Hemorrhagic; Trimethaphan | 1964 |
HISTAMINE-INDUCED HYPOTENSION DUE TO MORPHINE AND ARFONAD IN THE DOG.
Topics: Blood Chemical Analysis; Blood Pressure Determination; Dogs; Histamine; Hypotension; Morphine; Pharmacology; Research; Trimethaphan | 1963 |
[Some hemodynamic and gas-exchange changes in the lesser circulation during induced arterial hypotension produced with arfonad].
Topics: Blood Circulation; Hemodynamics; Humans; Hypotension; Hypotension, Controlled; Trimethaphan | 1961 |
A comparison of the effects of general hypothermia and arfonad-induced hypotension on survival of dogs after temporary acute occlusion of the portal vein.
Topics: Animals; Disease; Dogs; Hypotension; Hypotension, Controlled; Hypothermia; Hypothermia, Induced; Liver; Portal Vein; Trimethaphan; Vascular Diseases | 1960 |
[Dose-effect relation of arfonad & variations of the hypotensive effect caused by repetition of the same dose].
Topics: Autonomic Agents; Hypotension; Insulin; Trimethaphan | 1958 |
[Cerebral hemodynamics and oxygen and glucose consumption of the brain during prolonged hypotension induced by arfonad].
Topics: Autonomic Agents; Brain; Glucose; Hemodynamics; Hemorrhage; Hypotension; Hypotension, Controlled; Metabolism; Oxygen; Trimethaphan | 1958 |
[Controlled hypotension with arfonad in general & urological surgery].
Topics: Autonomic Agents; Hypotension; Hypotension, Controlled; Surgical Procedures, Operative; Trimethaphan; Urinary Tract | 1958 |
[Controlled hypotension with arfonad in neurosurgery].
Topics: Humans; Hypotension; Hypotension, Controlled; Neurosurgery; Neurosurgical Procedures; Trimethaphan | 1957 |
[Experience with experiments on animals in artificial hypotension with arfonad].
Topics: Autonomic Agents; Hypotension; Trimethaphan | 1957 |
[Changes in oxygen tension of the cerebral cortex in hypotension induced by arfonad (preparation RO2-2222, Roche)].
Topics: Autonomic Agents; Cerebral Cortex; Humans; Hypotension; Oxygen; Trimethaphan | 1957 |
[Controlled hypotension in anesthesia with a derivative of thiophanium, arfonad (RO 2-2222)].
Topics: Anesthesia; Anesthesiology; Hypotension; Hypotension, Controlled; Sympatholytics; Trimethaphan | 1956 |
[Bloodless surgery by means of hypotension caused by arfonad].
Topics: Bloodless Medical and Surgical Procedures; Humans; Hypotension; Sympatholytics; Trimethaphan | 1956 |
[Arfonad in neurosurgery].
Topics: Brain; Hypotension; Neurosurgery; Neurosurgical Procedures; Psychosurgery; Sympatholytics; Trimethaphan | 1956 |
Hypotension from arfonad; an aid in the surgical treatment of patent ductus arteriosus in older patients.
Topics: Aged; Disease; Ductus Arteriosus; Ductus Arteriosus, Patent; Humans; Hypotension; Sympatholytics; Trimethaphan | 1956 |
[Controlled hypotension by means of arfonad in otorhinolaryngology].
Topics: Autonomic Agents; Ear; Hypotension; Hypotension, Controlled; Otolaryngology; Otologic Surgical Procedures; Trimethaphan | 1956 |
[Personal experience with arfonad (R O 2-2222)].
Topics: Autonomic Agents; Humans; Hypotension; Hypotension, Controlled; Trimethaphan | 1956 |
Urinary excretion of arfonad by patients under going controlled hypotension during surgery.
Topics: Hypotension; Hypotension, Controlled; Sympatholytics; Trimethaphan; Urine | 1955 |
[Controlled hypotension with arfonad; preliminary report].
Topics: Hypotension; Hypotension, Controlled; Sympatholytics; Trimethaphan | 1955 |
[Clinical test of arfonad].
Topics: Hypotension; Sympatholytics; Trimethaphan | 1955 |
[Arfonad as a means of bloodless surgery under hypotension].
Topics: Bloodless Medical and Surgical Procedures; Humans; Hypotension; Sympatholytics; Trimethaphan | 1955 |
[Dosage of arfonad in artificial hypotension].
Topics: Hypotension; Hypotension, Controlled; Sympatholytics; Trimethaphan | 1955 |
Arfonad in neurosurgical anaesthesia.
Topics: Aged; Analgesia; Anesthesia; Anesthesia and Analgesia; Humans; Hypotension; Neurosurgery; Pain Management; Sympatholytics; Trimethaphan | 1955 |
Controlled hypotension in neurosurgery; clinical experiences with arfonad and hibernal.
Topics: Analgesia; Anesthesia; Anesthesia and Analgesia; Hypotension; Hypotension, Controlled; Neurosurgery; Pain Management; Sympatholytics; Trimethaphan | 1955 |
[Controlled hypotension and arfonad].
Topics: Hypotension; Hypotension, Controlled; Sympatholytics; Trimethaphan | 1955 |
[Use of a new ganglioplegic, arfonad, in controlled hypotension in otorhinolaryngological surgery].
Topics: Hypotension; Hypotension, Controlled; Otolaryngology; Otorhinolaryngologic Surgical Procedures; Sympatholytics; Trimethaphan | 1955 |
Further experiences with arfonad.
Topics: Hypotension; Sympatholytics; Trimethaphan | 1955 |
Effect of controlled hypotension with pendiomid (as used in surgery) on renal hemodynamics and water and electrolyte excretion: a comparison with hexamethonium and arfonad and the effect of norepinephrine on these responses.
Topics: Autonomic Agents; Electrolytes; Hemodynamics; Hexamethonium; Humans; Hypotension; Hypotension, Controlled; Kidney; Muscle Relaxants, Central; Norepinephrine; Sympatholytics; Trimethaphan; Water | 1955 |
Clinical report on controlled hypotension with arfonad.
Topics: Hypotension; Hypotension, Controlled; Sympatholytics; Trimethaphan | 1955 |
Arfonad hypotension for partial hepatectomy.
Topics: Hepatectomy; Hypotension; Liver; Sympatholytics; Trimethaphan | 1955 |
Controlled hypotension with arfonad in paediatric surgery.
Topics: Child; Hypotension; Hypotension, Controlled; Pediatrics; Specialties, Surgical; Sympatholytics; Trimethaphan | 1955 |
[Hypotension controlled by arfonad in brain surgery; first results].
Topics: Brain; Hypotension; Psychosurgery; Split-Brain Procedure; Sympatholytics; Trimethaphan | 1955 |
The use of arfonad in controlled hypotension.
Topics: Hypotension; Hypotension, Controlled; Trimethaphan | 1954 |
Controlled hypotension with arfonad.
Topics: Hypotension; Hypotension, Controlled; Sympatholytics; Trimethaphan | 1954 |
Controlled hypotension. II. A preliminary report on arfonad (RO 2-2222).
Topics: Hypotension; Hypotension, Controlled; Sympatholytics; Trimethaphan | 1954 |
Thimethaphan camphorsulfonate (arfonad) in general surgery.
Topics: Hypotension; Hypotension, Controlled; Specialties, Surgical; Sympatholytics; Trimethaphan | 1954 |
The use of arfonad in a modification of the technique of controlled hypotension.
Topics: Hypotension; Hypotension, Controlled; Sympatholytics; Trimethaphan | 1954 |
[Hypotension controlled with Arfonad (Ro 2-2222) with special consideration for neurosurgical interventions: clinical and experimental research].
Topics: Analgesia; Anesthesia; Anesthesia and Analgesia; Hypotension; Hypotension, Controlled; Neurosurgery; Pain Management; Sympatholytics; Trimethaphan | 1954 |
Cerebral hemodynamics during controlled hypotension induced by the continuous infusion of ganglionic blocking agents (hexamethonium, pendiomide and arfonad).
Topics: Autonomic Agents; Brain; Ganglionic Blockers; Hemodynamics; Hexamethonium; Hypotension; Hypotension, Controlled; Muscle Relaxants, Central; Sympatholytics; Trimethaphan | 1954 |
The use of arfonad in the production of controlled hypotension.
Topics: Hypotension; Hypotension, Controlled; Sympatholytics; Trimethaphan | 1954 |
[Arfonad in controlled hypotension during anesthesia].
Topics: Anesthesia; Anesthesiology; Hypotension; Hypotension, Controlled; Sympatholytics; Trimethaphan | 1954 |
[Controlled hypotension with arfonad in brain surgery].
Topics: Brain; Hypotension; Hypotension, Controlled; Sympatholytics; Trimethaphan | 1954 |
[Arfonad in comparison to classic ganglioplegics in their neurosurgical application].
Topics: Analgesia; Anesthesia; Anesthesia and Analgesia; Autonomic Agents; Hypotension; Hypotension, Controlled; Neurosurgery; Sympatholytics; Trimethaphan | 1954 |
[Controlled hypotension with arfonad, a ganglion blocking agent with temporary action; first clinical results].
Topics: Ganglionic Blockers; Hypotension; Hypotension, Controlled; Sympatholytics; Trimethaphan | 1954 |
[First attempts of controlled hypotension with arfonad].
Topics: Hypotension; Hypotension, Controlled; Sympatholytics; Trimethaphan | 1954 |
The intravenous use of a thiophanium derivative, arfonad-R02-2222, for the production of flexible and rapidly reversible hypotension during surgery.
Topics: Hypotension; Injections, Intravenous; Sympatholytics; Trimethaphan | 1953 |
Controlled hypotension; a study on arfonad (RO 2-2222).
Topics: Hypotension; Hypotension, Controlled; Sympatholytics; Trimethaphan | 1953 |
Controlled hypotension with arfonad in neurosurgery with special reference to vascular lesions.
Topics: Hypotension; Hypotension, Controlled; Neurosurgery; Neurosurgical Procedures; Sympatholytics; Trimethaphan | 1953 |
[A new controllable hypotensive: Ro 2-2222 (Arfonad)].
Topics: Hypotension; Sympatholytics; Trimethaphan | 1953 |